Corporate Profile

building

Mission

To develop, acquire and market superior products and services that will improve the quality of life for patients in the communities we serve.

Vision

Dilon will become a major participant in the diagnostics imaging business.

Summary

Dilon Diagnostics®, located in Newport News, Virginia, U.S.A., designs, manufactures and commercializes innovative medical imaging solutions worldwide based on cooperative research and development with the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility and leading medical universities.

Dilon provides complete digital solutions in diagnostic and surgical imaging.

Diagnostic Imaging:

Dilon’s cornerstone product, the Dilon Molecular Imaging System, is a high-resolution, compact camera, and is available in two sizes. This compact camera is ideal for imaging small body parts, such as the breast, thyroid, parathyroid and bone. The Dilon Molecular Imaging System has been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. The MBI procedure and its accessory for MBI guided breast biopsy has proven to detect cancers missed by Mammography and Ultrasound, while leading to fewer benign biopsies than MRI.

Dilon is the exclusive international distributor (most countries outside the U.S.) of Digirad’s lines of molecular imaging cameras including the ergo™, a large field-of-view general purpose imaging system, the Cardius® x.act, a triple-head cardiac dedicated SPECT imaging system with VCT Attenuation Correction, and the Cardius® XPO dedicated cardiac SPECT imaging systems line.

Surgical Imaging:

The Navigator® Gamma Probe is one of the most widely used gamma probes for cancer surgery in the marketplace. The Dilon Navigator 2.0 combines the reliability and features of its predecessor, the Navigator GPS, with state-of-the-art wireless probe technology in a new, sleek design. Lightweight and compact, this system is the ultimate in portability. The advanced battery technology allows for optimal placement of the control unit in the OR without the limitation associated with power cords.

Dilon is the exclusive U.S. distributor of SurgicEye’s declipseSPECT, the world’s first intra-operative handheld 3D tumor imaging and navigation solution for radio-guided surgery. This intraoperative solution provides image viewing, localization and depth information, as well as the uptake level of radioactively labeled structures like tumors and sentinel lymph nodes.